ClinicaliQ Trial Snapshot
- A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) — Recruiting • Phase II • Respiratory / COPD / Asthma • NCT07116031.
- This is an open-label, single group, Phase 1/2, 1-arm study for treatment of children aged 1 to.
- Sponsor: Sanofi.
Verify eligibility, endpoints and current status on the original source registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This is an open-label, single group, Phase 1/2, 1-arm study for treatment of children aged 1 to
Eligibility Snapshot
- : * Participant must be 1 to 1.5 × ULN (>3 x ULN if Gilbert's syndrome) * Glomerular filtration rate (GFR)
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.